Dr. Elizabeth P. Harausz, MD

Dr. Harausz practices at Upstate University Hospital in Syracuse, New York, part of State University of New York.

Dr. Harausz's NPI, 1699890012, was assigned on March 21, 2007. Dr. Harausz graduated from Tufts University School Of Medicine in 2007. Dr. Harausz holds New York license 256267.

Dr. Harausz's primary practice is Upstate University Hospital, at 750 East Adams Street, Syracuse, NY 13210 in Onondaga County. The practice phone is (315) 473-4240.

Dr. Harausz's primary practice is Upstate University Hospital in Syracuse, New York, part of State University of New York. Dr. Harausz is also affiliated with Crouse Hospital. The medical group on file is Department of Medicine. Dmand AI also links Dr. Harausz to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harausz practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Harausz's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Harausz is licensed in New York.

CMS data shows 167 Medicare services from Dr. Harausz across 5 procedure codes in 2024, for 127 Medicare patients. Medicare paid $18,193 for them.

CMS counts 127 Medicare patients who saw Dr. Harausz in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harausz's median patient age at 63, with 45% women.

In 2024, Dr. Harausz wrote 235 Medicare Part D claims for 31 patients. 80% of them were for generic drugs. CMS names the drug for 199 of them, across 6 drugs with 11 or more claims each, at $657,771 in total drug cost. In 2023, CMS named 159 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Harausz for performance year 2024, reported as part of a group. Dr. Harausz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harausz as offering telehealth.

Dmand AI links 15 papers to Dr. Harausz, published from 2015 to 2023. 2015 was the busiest year, with 2. The most frequent topics are Tuberculosis, Multidrug-Resistant, Antitubercular Agents and Mycobacterium tuberculosis. Dr. Harausz has published most often in Int J Tuberc Lung Dis. Dr. Harausz's most frequent co-authors are Jennifer J. Furin, MD, PhD, Anthony J. Garcia-Prats, MD and Farhana Amanullah, MD.

Dmand AI links Dr. Harausz to 1 clinical trial. Conditions studied include Dengue and Flavivirus Infections.

CMS Open Payments shows 15 general payments to Dr. Harausz from 1 drug or device company from 2019 to 2024. Consulting fees make up the largest share, 76% of the total. Insmed, Inc. paid the most, $6,009.

Dr. Harausz graduated from Tufts University School Of Medicine in 2007.